CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale SVP, Head of Finance & Admin. sold 13,000 shares at $24.34 ($316,420)
- 4 Open-market buy Director bought 1,714,285 shares at $17.50 ($29,999,988)
- 4 Planned sale CEO & President sold 269,719 shares at an average $18.66 ($5,032,915)
- 4 Planned sale Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)
- 4 Planned sale Chief Business Officer sold 31,900 shares at an average $16.59 ($529,194)
- 4 Planned sale SVP, Head of Finance & Admin. sold 13,000 shares at $18.81 ($244,530)
- 4 Planned sale See Remarks sold 2,376 shares at $12.02 ($28,560)
- 4 Open-market sale See Remarks sold 1,380 shares at $10.72 ($14,794)
- 4 Open-market sale Chief Business Officer sold 1,245 shares at $10.72 ($13,346)
- 4 Open-market sale Chief Operating Officer sold 1,616 shares at $10.72 ($17,324)
- 4 Planned sale Chief Medical Officer sold 2,666 shares at an average $10.66 ($28,413)
- 4 Open-market sale See Remarks sold 7,585 shares at $10.72 ($81,311)
- 4 Open-market sale Chief Scientific Officer sold 1,467 shares at $10.72 ($15,726)
- 4 Planned sale See Remarks sold 2,553 shares at $12.01 ($30,662)
- 4 Grant or award See Remarks acquired 89,742 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 96,158 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 94,893 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 82,512 shares (grant or award)
- 4 Grant or award See Remarks acquired 358,877 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 93,718 shares (grant or award)
Page 11 of 19 · 365 filings